★ Daily Intelligence Briefings (DIBs)Biotechnology & HealthcareMarketsPolitics & Policy Psychedelics Break New Ground in Clinical Trials, Research to be Bolstered by Key FDA Guidance New FDA guidance meant to steer clinical trials of psychedelic compounds will play a major role in the eventual approval…McAlinden Research PartnersJuly 12, 2023
★ Daily Intelligence Briefings (DIBs)⦁ Theme TrackerBiotechnology & HealthcareⓁ Gene EditingMarkets FDA Could Approve First CRISPR Treatment in US Before Year End, Marking New Territory for Gene Editing Tech CRISPR gene editing therapies took a big step toward commercialization in the United States last week, as the FDA laid…McAlinden Research PartnersJune 13, 2023